Is the Guzman y Gomez (GYG) share price 'too high'?

One broker is urging caution.

| More on:
I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Guzman y Gomez Ltd (ASX: GYG) share price has caught the attention of investors since its much-hyped public listing earlier this year.

Shares in the Mexican fast-food chain have lifted almost 70% since its initial public listing (IPO) in June at $22, now swapping hands at $37.37 apiece on Friday.

After this impressive run, analysts have chimed in – and their opinions are mixed. Let's see what's in store for the GYG share price.

Created with Highcharts 11.4.3Guzman Y Gomez PriceZoom1M3M6MYTD1Y5Y10YALL20 Jun 20246 Sep 2024Zoom ▾24 Jun1 Jul8 Jul15 Jul22 Jul29 Jul5 Aug12 Aug19 Aug26 Aug2 Sep1 Jul1 Jul15 Jul15 Jul29 Jul29 Jul12 Aug12 Aug26 Aug26 Augwww.fool.com.au

Broker downgrades GYG shares

In its first ASX earnings results, Guzman y Gomez reported network sales growth of 26% for FY24, with comparable store sales up 8%.

As my colleague Mitch reported, these results were ahead of Domino's Pizza Enterprises Ltd (ASX: DMP) reported just 2.8% same-store sales growth, while Collins Food Ltd (ASX: CKF), which operates KFC and Taco Bell, posted 3.8%.

While the fast-food chain delivered stronger-than-expected FY24 results, UBS has flagged that its current valuation might be getting ahead of itself.

According to The Australian, UBS analyst Shaun Cousins has downgraded Guzman y Gomez to a sell rating despite raising the 12-month target price by 13% to $35.

Despite the upside risks to its FY25 earnings outlook, UBS remains cautious. The broker notes that the company's share price has surged beyond what earnings forecasts can justify, especially given the current economic climate.

Due to share price outperformance since its 20-Jun-24 IPO, the multiple has expanded off already above-Prospectus earnings estimates, making the current risk- reward unattractive, in our view.

While the company's strong brand presence and rapid expansion in the quick-service restaurant (QSR) market make it a favourite among investors, UBS believes the risks currently outweigh the rewards.

The bullish take on GYG

Not all brokers share the same bearish outlook. Morgan Stanley is bullish on the GYG share price, initiating coverage with a buy rating and a price target of $31.80 last month.

Morgan Stanley highlights Guzman y Gomez's unit economics, growth across multiple markets, and its ability to scale effectively in its thesis.

Fund managers are also piling into the company. Firetrail Investments, for example, is bullish on the fast-growing QSR, and emphasises the franchise's profitability.

According to Firetrail, Guzman y Gomez's drive-through stores generate around $6.1 million in average annual revenue, with a payback period of just 18 months. That rapid return on investment is surpassed only by McDonald's.

Of course, the case isn't without risks. Despite its rapid expansion, Guzman y Gomez reported a statutory loss of about $14 million in FY24 versus a $2 million loss in FY23.

This is something that could weigh in moving forward.

Foolish takeout

The GYG share price continues to attract plenty of investors. The stock is well in the green since its listing, but some brokers are cautious on valuations.

Others see a long-term period of growth. Time will tell what side of the coin is correct.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Retired couple hugging and laughing.
Broker Notes

Why Macquarie expects this $2.5 billon ASX healthcare share to rocket 36%

Macquarie forecasts strong outperformance for this ASX healthcare share.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Ord Minnett names 2 ASX 200 shares to buy

These shares have been given the thumbs up from the broker.

Read more »

Woman relaxing on her phone on her couch, symbolising passive income.
Broker Notes

2 quality ASX 200 shares tipped to outperform

Leading experts say these two ASX 200 shares are on the growth path.

Read more »

Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Does Macquarie prefer Medibank Private or NIB shares?

Let's see what the broker thinks of these two blue chips.

Read more »

A large plane rolls down a runway with a sunny blue sky behind it as brokers reveal their outlook for the Flight Centre share price in FY23
Broker Notes

Macquarie tips this ASX All Ords travel stock to surge more than 65%

This travel stock is a bargain at current levels, Macquarie analysts say.

Read more »

Blue chip in a trolley with a man pushing it.
Broker Notes

Experts name 3 ASX 200 giants to sell today

Two top experts say it’s time to take profits on these outperforming ASX 200 giants.

Read more »

Doctor checking patient's spine x-ray image.
Broker Notes

This All Ords imaging company stock could return more than 50%, one broker says

Deregulation in the MRI sector will be a boon for this billion-dollar outfit, Bell Potter says.

Read more »